Drug pricing regulator the National Pharmaceutical Pricing Authority (NPPA) has said that  price of cancer drugs has been slashed by up to 86% since March 2016, providing relief to lakhs of patients. The reduction is in the price range of 86% to 13%, NPPA said. Earlier, the government had slashed the prices of coronary stents by up to 85%. 